Publication | Closed Access

Relation of Improvement in Endothelium-Dependent Flow-Mediated Vasodilation After Rosiglitazone to Changes in Asymmetric Dimethylarginine, Endothelin-1, and C-Reactive Protein in Nondiabetic Patients With the Metabolic Syndrome

Metabolic SyndromeVascular DiseaseCardiovascular DiseaseMedicineVascular AdaptationPhysiologyDiabetesEndothelial DysfunctionVascular BiologyMicrovascular DysfunctionPharmacologyAsymmetric DimethylarginineAtherosclerosisC-reactive ProteinHealth Sciences